Schedule your free initial consultation

Product Liability Update: FDA Investigates Risk of Diabetes Drugs

Product Liability Update: FDA Investigating Possible Increased Risk of Cancer from Popular Diabetes Drugs

The Food and Drug Administration and its European counterpart, the European Medicines Agency, recently announced that they are investigating whether a type of popular diabetes medication may cause an increased risk of pancreatitis and pancreatic cancer. The investigations center on a group of diabetes medications known as "incretin mimetics," which stimulate the release of insulin in diabetes patients. Some of the most commonly prescribed drugs in this class include Byetta, Januvia, Janumet, and Victoza.

The FDA investigation comes in the wake of a studies published in February in the JAMA Internal Medicine journal. The study, conducted by researchers at Johns Hopkins University School of Medicine, concluded that the use of incretin mimetic medications resulted in cellular changes that could double one's risk of developing pancreatitis and also increase their risk of pancreatic cancer. A subsequent study reaching a similar conclusion was published in March in the medical journal Diabetes.

The FDA is advising patients currently using these drugs to continue to take them as prescribed until they have the opportunity to speak with their doctors. You can read the FDA's March 14th press release here.

Dreyer Boyajian LLP represents clients who have been harmed by dangerous drugs, and has extensive experience in product liability litigation. If you or someone you know has been harmed by a defective drug, contact our office for a free consultation with an attorney.  To learn more about our practice, please visit our website.

No Comments

Leave a comment
Comment Information
We are committed to obtaining the justice that your case deserves.

Contact our team of Attorneys

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

Office Location

Dreyer Boyajian LLP
75 Columbia Street
Albany, NY 12210

Toll Free: 866-292-1582
Phone: 518-478-2762
Phone: 518-478-2762
Fax: 518-463-4039
Albany Law Office Map